Challenging assumptions about minority participation in US clinical research

American Journal of Public Health

Volumn 101, Issue 12, 2011, Pages 2217-2222

  Fisher, Jill A ^a   Kalbaugh, Corey A ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; ARTICLE; CLINICAL TRIAL (TOPIC); HISPANIC; HUMAN; MINORITY GROUP; PATIENT PARTICIPATION; PATIENT SELECTION; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); RESEARCH ETHICS; STATISTICS; UNITED STATES;

AFRICAN AMERICANS; CLINICAL TRIALS AS TOPIC; CLINICAL TRIALS, PHASE I AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; ETHICS, RESEARCH; HISPANIC AMERICANS; HUMANS; MINORITY GROUPS; PATIENT PARTICIPATION; PATIENT SELECTION; UNITED STATES;

EID: 81555196102     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2011.300279     Document Type: Article

References (54)

1. Epstein S. Inclusion: The Politics of Difference in Medical Research. Chicago: University of Chicago Press; 2007.
2. US Census Bureau. National Population Estimates, July 1 and April 1, 2000 to July 1, 2008. Available at: http://www.census.gov/popest/overview.html. Accessed July 4, 2011.
3. Pinn VW, Roth C, Bates AC, Wagner R, Jarema K. Monitoring Adherence to the NIH Policy on the Inclusion of Women and Minorities as Subjects in Clinical Research (Comprehensive Report: Fiscal Year 2007 and 2008 Tracking Data). Bethesda, MD: National Institutes of Health, Department of Health and Human Services; 2009.
4. Evelyn B, Toigo T, Banks D, et al. Participation of racial/ethnic groups in clinical trials and race-related labeling: a review of new molecular entities approved 1995-1999. J Natl Med Assoc. 2001;93(suppl 12):18S-24S. (Pubitemid 33741650)
5. Lamberti MJ, ed. State of the Clinical Trials Industry: A Sourcebook of Charts and Statistics. Boston: CenterWatch; 2009.
6. Jones JH. Bad Blood: The Tuskegee Syphilis Experiment. New York: Free Press; 1981.
7. Corbie-Smith G, Thomas SB, St. George D M M. Distrust, race, and research. Arch Intern Med. 2002;162(21):2458-2463. (Pubitemid 35340462)
8. Brown DR, Topcu M. Willingness to participate in clinical treatment research among older African Americans and Whites. Gerontologist. 2003;43(1):62-72. (Pubitemid 36222695)
9. Faden RR, Beauchamp TL. A History and Theory of Informed Consent. New York: Oxford University Press; 1986.
10. Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med. 1999;14(9):537-546. (Pubitemid 29441632)
11. Corbie-Smith GM. Minority recruitment and participation in health research. N C Med J. 2004;65(6):385-387.
12. Gamble VN. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health. 1997;87(11):1773-1778. (Pubitemid 127471142)
13. Katz RV, Green BL, Kressin NR, Claudio C, Wang MQ, Russell SL. Willingness of minorities to participate in biomedical studies: confirmatory findings from a follow-up study using the Tuskegee Legacy Project questionnaire. J Natl Med Assoc. 2007;99(9):1052-1060. (Pubitemid 47463291)
14. Katz RV, Green BL, Kressin NR, et al. Exploring the "legacy" of the Tuskegee Syphilis Study: a follow-up study from the Tuskegee Legacy Project. J Natl Med Assoc. 2009;101(2):179-183.
15. Katz RV, Kegeles SS, Green BL, Kressin NR, James SA, Claudio C. The Tuskegee Legacy Project: history, preliminary scientific findings, and unanticipated societal benefits. Dent Clin North Am. 2003;47(1):1-19. (Pubitemid 38962240)
16. Katz RV, Kegeles SS, Kressin NR, et al. Awareness of the Tuskegee Syphilis Study and the US presidential apology and their influence on minority participation in biomedical research. Am J Public Health. 2008;98(6):1137-1142. (Pubitemid 351793396)
17. Paskett ED, Reeves KW, McLaughlin JM, et al. Recruitment of minority and underserved populations in the United States: the Centers for Population Health and Health Disparities experience. Contemp Clin Trials. 2008;29(6):847-861.
18. Shavers-Hornaday VL, Lynch CF, Burmeister LF, Torner JC. Why are African Americans under-represented in medical research studies? Impediments to participation. Ethn Health. 1997;2(1-2):31-45. (Pubitemid 27292301)
19. Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academy of Sciences; 2003.
20. Svensson CK. Representation of American Blacks in clinical trials of new drugs. JAMA. 1989;261(2):263-265. (Pubitemid 19032974)
21. Swanson GM, Ward AJ. Recruiting minorities into clinical trials: toward a participant-friendly system. J Natl Cancer Inst. 1995;87(23):1747-1759.
22. Wendler D, Kington R, Madans J, et al. Are racial and ethnic minorities less willing to participate in health research? PLoS Med. 2006;3(2):e19.
23. Freedman TG. "Why don't they come to Pike Street and ask us?": Black American women's health concerns. Soc Sci Med. 1998;47(7):941-947. (Pubitemid 28370543)
24. Savitt TL. The use of Blacks for medical experimentation and demonstration in the Old South. J South Hist. 1982;48(3):331-348.
25. Schulman KA, Berlin JA, Harless W, et al. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med. 1999;340(8):618-626. (Pubitemid 29093722)
26. van Ryn M, Burke J. The effect of patient race and socio-economic status on physicians' perceptions of patients. Soc Sci Med. 2000;50(6):813-828. (Pubitemid 30058264)
27. Hasnain-Wynia R, Baker DW, Nerenz D, et al. Disparities in health care are driven by where minority patients seek care. Examination of the hospital quality alliance measures. Arch Intern Med. 2007;167(12):1233-1239. (Pubitemid 46998493)
28. Jha AK, Orav EJ, Li Z, Epstein AM. Concentration and quality of hospitals that care for elderly Black patients. Arch Intern Med. 2007;167(11):1177-1182. (Pubitemid 46919821)
29. Regenbogen SE, Gawande AA, Lipsitz SR, Greenberg CC, Jha AK. Do differences in hospital and surgeon quality explain racial disparities in lower-extremity vascular amputations? Ann Surg. 2009;250(3):424-431.
30. Joseph G, Dohan D. Recruiting minorities where they receive care: institutional barriers to cancer clinical trials recruitment in a safety net hospital. Contemp Clin Trials. 2009;30(6):552-559.
31. Regenstein M, Huang J. Stresses to the Safety Net: The Public Hospital Perspective. Washington, DC: Kaiser Family Foundation; 2005.
32. McCarthy CR. Historical background of clinical trials involving women and minorities. Acad Med. 1994;69(9):695-698. (Pubitemid 24289937)
33. Brandon DT, Isaac LA, LaVeist TA. The legacy of Tuskegee and trust in medical care: is Tuskegee responsible for race differences in mistrust of medical care? J Natl Med Assoc. 2005;97(7):951-956. (Pubitemid 40967398)
34. Pinnow E, Sharma P, Parekh A, Gevorkian N, Uhl K. Increasing participation of women in early phase clinical trials approved by the FDA. Womens Health Issues. 2009;19(2):89-93.
35. Wood SF. Tracking inclusion of women in clinical studies. J Womens Health (Larchmt). 2009;18(3):301-310.
36. Yang Y, Carlin AS, Faustino PJ, et al. Participation of women in clinical trials for new drugs approved by the Food and Drug Administration in 2000-2002. J Womens Health (Larchmt). 2009;18(3):303-310.
37. Fisher JA. Medical Research for Hire: The Political Economy of Pharmaceutical Clinical Trials. New Brunswick, NJ: Rutgers University Press; 2009.
38. Corrigan OP. "First in man": the politics and ethics of women in clinical drug trials. Fem Rev. 2002;72:40-52.
39. Fisher JA. "Ready-to-recruit" or "ready-to-consent" populations?: informed consent and the limits of subject autonomy. Qual Inq. 2007;13(6):875-894.
40. Lemmens T, Miller PB. The human subjects trade: ethical and legal issues surrounding recruitment incentives. J Law Med Ethics. 2003;31(3):398-418. (Pubitemid 39307076)
41. Tishler CL, Bartholomae S. The recruitment of normal healthy volunteers: a review of the literature on the use of financial incentives. J Clin Pharmacol. 2002;42(4):365-375. (Pubitemid 34259769)
42. Lemmens T, Elliott C. Justice for the professional guinea pig. Am J Bioeth. 2001;1(2):51-53.
43. Weinstein M. A public culture for guinea pigs: U. S. human research subjects after the Tuskegee study. Sci Cult. 2001;10(2):195-223.
44. Helms R, ed. Guinea Pig Zero: An Anthology of the Journal for Human Research Subjects. New Orleans: Garrett County Press; 2005.
45. Abadie R. The Professional Guinea Pig: Big Pharma and the Risky World of Human Subjects. Durham, NC: Duke University Press; 2010.
46. Elliott C, Abadie R. Exploiting a research underclass in phase 1 clinical trials. N Engl J Med. 2008;358(22):2316-2317. (Pubitemid 351749155)
47. Kass NE, Myers R, Fuchs EJ, Carson KA, Flexner C. Balancing justice and autonomy in clinical research with healthy volunteers. Clin Pharmacol Ther. 2007;82(2):219-227. (Pubitemid 47075333)
48. Wood A J J, Darbyshire J. Injury to research volunteers: the clinical research nightmare. N Engl J Med. 2006;354(18):1869-1871. (Pubitemid 43872686)
49. Beauchamp TL, Jennings B, Kinney ED, Levine RJ. Pharmaceutical research involving the homeless. J Med Philos. 2002;27(5):547-564. (Pubitemid 35434538)
50. McNeill P. Paying people to participate in research: why not? A response to Wilkinson and Moore. Bioethics. 1997;11(5):390-396.
51. Grady C. Money for research participation: does it jeopardize informed consent? Am J Bioeth. 2001;1(2):40-44.
52. Stones M, McMillan J. Payment for participation in research: a pursuit for the poor? J Med Ethics. 2010;36(1):34-36.
53. Cooper M. Experimental labour: offshoring clinical trials to China. East Asian Sci Technol Soc. 2008;2:73-92.
54. Shah S. The Body Hunters: How the Drug Industry Tests Its Products on the World's Poorest Patients. New York: The New Press; 2006.